Researchers from Rutgers believe themselves among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—the antiviral medication that helps keep high-risk patients out of the hospital and from dying.
from Medical Xpress - latest medical and health news stories https://ift.tt/R8w9BbH
